Wald; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wald; David.The latest application filed is for "securinine and norsecurinine analogue compounds for the treatment of myeloid disorders".

Company Profile

3.13.16

Wald; David - Shaker Heights OH
Wald; David - Cleveland OH
WALD; David - Calgary CA
Wald; David - University Heights OH
Wald; David - Watertown MA
Wald; David - Santa Clara CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Securinine And Norsecurinine Analogue Compounds For The Treatment Of Myeloid Disorders App 20210220341 - Agarwal; Mukesh ; et al.	2021-07-22
Securinine and norsecurinine analogue compounds for the treatment of myeloid disorders Grant 10,806,723 - Agarwal , et al. October 20, 2	2020-10-20
Myeloid differentiation inducing agents Grant 10,300,049 - Wald	2019-05-28
Securinine And Norsecurinine Analogue Compounds For The Treatment Of Myeloid Disorders App 20190083472 - Agarwal; Mukesh ; et al.	2019-03-21
HDMX inhibitors and their use for cancer treatment Grant 10,183,912 - Wald , et al. Ja	2019-01-22
Small molecule securinine and norsecurinine analogs and their use in inhibiting myeloperoxidase Grant 10,149,838 - Gundluru , et al. Dec	2018-12-11
Securinine and norsecurinine analogue compounds for the treatment of myeloid disorders Grant 10,130,616 - Agarwal , et al. November 20, 2	2018-11-20
Small molecule securinine and norsecurinine analogs and their use in cancers, inflammatory diseases and infections Grant 9,827,229 - Gundluru , et al. November 28, 2	2017-11-28
Novel Hdmx Inhibitors And Their Use For Cancer Treatment App 20170022166 - Wald; David ; et al.	2017-01-26
Virtual Packaging And Electronic Gifting System And Methodology App 20170024802 - SORENSEN; Kim ; et al.	2017-01-26
Myeloid Differentiation Inducing Agents App 20170000774 - Wald; David	2017-01-05
Securinine And Norsecurinine Analogue Compounds For The Treatment Of Myeloid Disorders App 20160263089 - Agarwal; Mukesh ; et al.	2016-09-15
Myeloid differentiation inducing agents Grant 9,439,894 - Wald September 13, 2	2016-09-13
Small Molecule Securinine And Norsecurinine Analogs And Their Use In Inhibiting Myeloperoxidase App 20160250196 - Gundluru; Mahesh K. ; et al.	2016-09-01
Small Molecule Securinine And Norsecurinine Analogs And Their Use In Cancers, Inflammatory Diseases And Infections App 20160229861 - Gundluru; Mahesh K. ; et al.	2016-08-11
Myeloid differentiation inducing agents Grant 8,815,827 - Wald August 26, 2	2014-08-26
Virtual Packaging And Electronic Gifting System And Methodology App 20140058873 - SORENSEN; Kim ; et al.	2014-02-27
Myeloid Differentiation Inducing Agents App 20140018383 - Wald; David	2014-01-16
Data quality tracking Grant 8,046,385 - Wald , et al. October 25, 2	2011-10-25
Myeloid Differentiation Inducing Agents App 20100267656 - Wald; David	2010-10-21
Data Quality Tracking App 20090319566 - Wald; David ; et al.	2009-12-24
Step over walking aid App 20070130803 - Levy; Bernard ; et al.	2007-06-14
Step over walking aid App 20070130804 - Levy; Bernard ; et al.	2007-06-14
High Speed Thermal Duplication Of Magnetic Tape Grant 3,825,948 - Hendershot, III , et al. July 23, 1	1974-07-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.